Study of STRO-001, an Anti-CD74 Antibody Drug Conjugate, in Patients With Advanced B-Cell Malignancies
B-cell Lymphoma Non Hodgkin Lymphoma Multiple Myeloma Follicular Lymphoma Mantle Cell Lymphoma Diffuse Large B Cell Lymphoma Indolent Lymphoma B Cells--Tumors Lymphoma Lymphoma, B-Cell Lymphoma, Mantle-Cell Lymphoma, Large B-Cell, Diffuse Antibodies Immunoconjugates STRO-001
Lead Scientist at UCSF
- Nina Shah
Dr. Nina Shah is a hematologist who specializes in the treatment of multiple myeloma, a type of cancer affecting the blood marrow. She treats patients at the Hematology and Blood Marrow and Transplant Clinic. Nina received a bachelor’s degree in cognitive neuroscience at Harvard University, followed by a medical degree from New York University School of Medicine.
- accepting new patients
- Start Date
- Completion Date
- Sutro Biopharma, Inc.
- ASH conference, Dec 2017 oral presentation NHL abstract
- ASH conference, Dec 2017 poster presentation multiple myeloma abstract
- Phase 1
- Study Type
- Last Updated